Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Finn

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Biochemistry|May 30, 1989
18F-labeled insulin: a prosthetic group methodology for incorporation of a positron emitter into peptides and proteinsY Shai, K L Kirk, M A Channing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1995
Pilot radioimmunotherapy trial with 131I-labeled murine monoclonal antibody CC49 and deoxyspergualin in metastatic colon carcinomaC R Divgi, A M Scott, S Gulec, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1989
Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3'-azido-2',3'-dideoxythymidine (AZT, zidovudine): a PET-FDG studyA Brunetti, G Berg, G Di Chiro, et al.
Nuclear Medicine and Biology|January 1, 1994
Clinical comparison of radiolocalization of two monoclonal antibodies (mAbs) against the TAG-72 antigenC R Divgi, A M Scott, K McDermott, et al.
Nuclear Medicine and Biology|July 1, 1994
Current status of radioimmunotherapyS M Larson, C R Divgi, A Scott, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1994
Imaging of brain tumor proliferative activity with iodine-131-iododeoxyuridineJ G Tjuvajev, H A Macapinlac, F Daghighian, et al.
International Journal of Cancer|July 18, 2000
Pharmacokinetics and microdistribution of polyethylene glycol-modified humanized A33 antibody targeting colon cancer xenograftsP M Deckert, A Jungbluth, N Montalto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclideD A Scheinberg, D Lovett, C R Divgi, et al.
Cancer|February 1, 1994
Murine and humanized constructs of monoclonal antibody M195 (anti-CD33) for the therapy of acute myelogenous leukemiaP C Caron, M A Schwartz, M S Co, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1991
Estimates of radiation absorbed dose for intraperitoneally administered iodine-131 radiolabeled B72.3 monoclonal antibody in patients with peritoneal carcinomatosesS M Larson, J A Carrasquillo, D C Colcher, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Biochemistry|May 30, 1989
18F-labeled insulin: a prosthetic group methodology for incorporation of a positron emitter into peptides and proteinsY Shai, K L Kirk, M A Channing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1995
Pilot radioimmunotherapy trial with 131I-labeled murine monoclonal antibody CC49 and deoxyspergualin in metastatic colon carcinomaC R Divgi, A M Scott, S Gulec, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1989
Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3'-azido-2',3'-dideoxythymidine (AZT, zidovudine): a PET-FDG studyA Brunetti, G Berg, G Di Chiro, et al.
Nuclear Medicine and Biology|January 1, 1994
Clinical comparison of radiolocalization of two monoclonal antibodies (mAbs) against the TAG-72 antigenC R Divgi, A M Scott, K McDermott, et al.
Nuclear Medicine and Biology|July 1, 1994
Current status of radioimmunotherapyS M Larson, C R Divgi, A Scott, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1994
Imaging of brain tumor proliferative activity with iodine-131-iododeoxyuridineJ G Tjuvajev, H A Macapinlac, F Daghighian, et al.
International Journal of Cancer|July 18, 2000
Pharmacokinetics and microdistribution of polyethylene glycol-modified humanized A33 antibody targeting colon cancer xenograftsP M Deckert, A Jungbluth, N Montalto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclideD A Scheinberg, D Lovett, C R Divgi, et al.
Cancer|February 1, 1994
Murine and humanized constructs of monoclonal antibody M195 (anti-CD33) for the therapy of acute myelogenous leukemiaP C Caron, M A Schwartz, M S Co, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1991
Estimates of radiation absorbed dose for intraperitoneally administered iodine-131 radiolabeled B72.3 monoclonal antibody in patients with peritoneal carcinomatosesS M Larson, J A Carrasquillo, D C Colcher, et al.
Pageof 9